Daya Drug Discoveries Inc.

Maryland Heights, MO

UEI
J9J6N8T2NG16
CAGE
4LWF4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Woman Owned Business
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
5 Worthington Access Dr, Maryland Heights, MO 63043, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Indolobenzox- and thiazepines as atypical antipsychotic agents R43MH084365 National Institutes of Health $175,694

Quick answers

Is Daya Drug Discoveries Inc. registered in SAM.gov?

Yes. Daya Drug Discoveries Inc.'s SAM.gov registration is active through June 10, 2027.

What is Daya Drug Discoveries Inc.'s most recent federal award?

Daya Drug Discoveries Inc.'s most recent federal grant award is Indolobenzox- and thiazepines as atypical antipsychotic agents (R43MH084365), from National Institutes of Health, on September 2, 2008.

On GovTribe

See Daya Drug Discoveries Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors